Trial Information

Summary: Randomized Study Comparing CNTO 1275 and Etanercept for the Treatment of Moderate to Severe Plaque Psoriasis

NYU School of Medicine is conducting a research study is to compare the effects of CNTO 1275 or EnbrelŪ (etanercept) on moderate to severe plaque psoriasis.

You may be eligible to participate in this study if you:

  • Are at least 18 years of age
  • Have had a diagnosis of plaque-type psoriasis at least 6 months prior to study

You may not participate in this study if you:

  • Are pregnant, nursing or intend to become pregnant during the study
  • Have participated in another research study within the last 30 days

Contact:

Elizabeth Camacho, Study Coordinator
Biomedical Research Alliance of New York
NYU School of Medicine
560 First Ave.
New York, NY 10016
Telephone: 212-263-5244
Fax: 212-263-6624
Email:

Profile Page: Biomedical Research Alliance of New York, New York, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: February 25, 2008 at 3:10:19 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA